The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human Use

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The objective of this study was to achieve the post-marketing safety and immunogenicity research of Speeda® rabies vaccine for human use from Chengda Bio
Epistemonikos ID: 00d18d3d4aec365627539e60377ed4d5dee7959b
First added on: May 11, 2024